CIPO trademark

REMKEYSI

FiledCIPOWord markClass 5

"REMKEYSI" is a word mark owned by Abivax, filed at the CIPO on October 9, 2026. It is filed and waiting for examination and covers class 5 (Pharmaceuticals).

View Abivax portfolioGet this data via the API
Official CIPO record
REMKEYSI
Word mark as filed with the CIPO
Status
Filed
Since October 9, 2026
Filed
October 9, 2026
Registered
Not yet
Priority date
October 8, 2026
Claimed from France
Application no.
2506759
Registration no.
Not yet
Office
CIPO
Canadian Intellectual Property Office
Mark type
Word mark
1 class
Ownership

Who owns REMKEYSI

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Abivax

France

6 trademarks in the portfolioView company

Representative

Robic Agence Pi S.E.C./ Robic IP Agency LP

Robic Agence Pi S.E.C./ Robic IP Agency LP

Goods and services

What the mark covers

The products and services REMKEYSI is filed for, grouped by Nice class.

  • Pharmaceutical preparations for the treatment of inflammatory diseases, immune-mediated and autoimmune diseases, disorders and conditions affecting the gastrointestinal tract, namely, inflammation associated with colon carcinoma, pouchitis, Inflammatory Bowel Disease, including Crohn's disease and Ulcerative Colitis, checkpoint inhibitor colitis and eosinophilic esophagitis; Chemical preparations for medical purposes for the treatment of inflammatory diseases, immune-mediated and autoimmune diseases, disorders and conditions affecting the gastrointestinal tract, namely, inflammation associated with colon carcinoma, pouchitis, Inflammatory Bowel Disease, including Crohn's disease and Ulcerative Colitis, checkpoint inhibitor colitis and eosinophilic esophagitis; Chemical preparations for pharmaceutical purposes for the treatment of inflammatory diseases, immune-mediated and autoimmune diseases, disorders and conditions affecting the gastrointestinal tract,namely, inflammation associated with colon carcinoma, pouchitis, Inflammatory Bowel Disease, including Crohn's disease and Ulcerative Colitis, checkpoint inhibitor colitis and eosinophilic esophagitis

History

What has happened so far

Steps recorded by the CIPO, newest first.

  1. Formalized
  2. Created
  3. Filed
FAQ

About REMKEYSI

Who owns the trademark "REMKEYSI"?

The CIPO trademark "REMKEYSI" (application 2506759) is owned by Abivax.

What is the status of "REMKEYSI"?

Its status at the CIPO is: filed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull REMKEYSI and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_01a13b99-17fb-7029-834f-d7542166cd19
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a13b99-17fb-7029-834f-d7542166cd19",
  "object": "trademark",
  "mark_text": "REMKEYSI",
  "status": {
    "primary": "pending",
    "stage": "filed"
  },
  "office_code": "CA",
  "application_number": "2506759",
  "filing_date": "2026-10-09",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "ABIVAX",
      "entity_id": "ent_019ebc12-6860-7741-a610-586c310973ea"
    }
  ]
}